NEW YORK, April 03, 2018 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Akorn, Inc. (NASDAQ:AKRX) who purchased shares between March 1, 2017 and February 26, 2018. The action, which was filed in the United States District Court for the District of Illinois, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) the Company’s failure to comply with FDA data integrity requirements would jeopardize Fresenius’ acquisition of the Company; (2) the Company lacked effective internal controls over financial reporting; and (3) as a result, the Company’s financial statements were materially false and misleading at all relevant times.
Shareholders have until May 7, 2018 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-c/akorn-inc?wire=3.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com


Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
GM Plans C$1.1 Billion Canada Investment Amid U.S. Tariff Pressure
Amazon Secures 200 MW Wind Power Deals in Sweden
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
Mercer International Stock Surges 45% on C$20 Million Canada Funding
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
Jefferies Names AMEC Top China Semiconductor Equipment Pick
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
OpenAI AI Agent Swarm Behind Hugging Face Hack
Street Poller Media and The Boom of the Street Interview Ad Industry
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 



